The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinoma

[1]  Yu-qin Pan,et al.  Retraction Notice to: YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner , 2022, Molecular therapy. Nucleic acids.

[2]  T. Ma,et al.  Biological roles of RNA m5C modification and its implications in Cancer immunotherapy , 2022, Biomarker research.

[3]  Chen Xue,et al.  A Novel m1A-Score Model Correlated With the Immune Microenvironment Predicts Prognosis in Hepatocellular Carcinoma , 2022, Frontiers in Immunology.

[4]  Jun Liu,et al.  Identification of the Expression Patterns and Potential Prognostic Role of 5-Methylcytosine Regulators in Hepatocellular Carcinoma , 2022, Frontiers in Cell and Developmental Biology.

[5]  Zhaohui S. Qin,et al.  UALCAN: An update to the integrated cancer data analysis platform , 2022, Neoplasia.

[6]  Shangqian Wang,et al.  Prognostic Role of DNA Damage Response Genes Mutations and their Association With the Sensitivity of Olaparib in Prostate Cancer Patients , 2022, Cancer control : journal of the Moffitt Cancer Center.

[7]  A. Tonevitsky,et al.  ECM–Receptor Regulatory Network and Its Prognostic Role in Colorectal Cancer , 2021, Frontiers in Genetics.

[8]  Lei He,et al.  N1-methyladenosine methylation in tRNA drives liver tumourigenesis by regulating cholesterol metabolism , 2021, Nature Communications.

[9]  M. Sugimoto,et al.  The Impact of m1A Methylation Modification Patterns on Tumor Immune Microenvironment and Prognosis in Oral Squamous Cell Carcinoma , 2021, International journal of molecular sciences.

[10]  J. Lou,et al.  RNA N6-Methyladenosine Patterns in Hepatocellular Carcinoma Reveal a Distinct Immune Infiltration Landscape and Clinical Significance , 2021, Medical science monitor : international medical journal of experimental and clinical research.

[11]  Qiaofeng Zhang,et al.  The role of RNA m5C modification in cancer metastasis , 2021, International journal of biological sciences.

[12]  Wenyi Wei,et al.  Cell cycle on the crossroad of tumorigenesis and cancer therapy. , 2021, Trends in cell biology.

[13]  Zi-Zi Chen,et al.  Prognostic signature and immune efficacy of m1A‐, m5C‐ and m6A‐related regulators in cutaneous melanoma , 2021, Journal of cellular and molecular medicine.

[14]  P. Shao,et al.  Identification of MX2 as a Novel Prognostic Biomarker for Sunitinib Resistance in Clear Cell Renal Cell Carcinoma , 2021, Frontiers in Genetics.

[15]  Xiaohan Ren,et al.  Multi‐omics analysis reveals the interaction between the complement system and the coagulation cascade in the development of endometriosis , 2021, Scientific Reports.

[16]  Fanqiang Meng,et al.  Identification of novel autophagy-related lncRNAs associated with a poor prognosis of colon adenocarcinoma through bioinformatics analysis , 2021, Scientific Reports.

[17]  Wei Zhang,et al.  Roles of RNA Methylation on Tumor Immunity and Clinical Implications , 2021, Frontiers in Immunology.

[18]  Yun-Gui Yang,et al.  RNA methylations in human cancers. , 2020, Seminars in cancer biology.

[19]  Yu-qin Pan,et al.  YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner , 2020, Molecular therapy. Nucleic acids.

[20]  S. M. Toor,et al.  Immune checkpoints in the tumor microenvironment. , 2020, Seminars in cancer biology.

[21]  Yanjuan Huang,et al.  m1A Regulator TRMT10C Predicts Poorer Survival and Contributes to Malignant Behavior in Gynecological Cancers. , 2020, DNA and cell biology.

[22]  Miao-jing Wu,et al.  Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma , 2020, Frontiers in Oncology.

[23]  Hongliang Liu,et al.  Novel genetic variants in genes of the Fc gamma receptor-mediated phagocytosis pathway predict non-small cell lung cancer survival , 2020, Translational lung cancer research.

[24]  Yuting He,et al.  Role of m 5 C-related regulatory genes in the diagnosis and prognosis of hepatocellular carcinoma , 2020 .

[25]  Yubin Zhou,et al.  RNA modifications and cancer , 2020, RNA biology.

[26]  Xuehao Wang,et al.  M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma , 2020, Journal of Hematology & Oncology.

[27]  Gang Yin,et al.  Functions of N6-methyladenosine and its role in cancer , 2019, Molecular Cancer.

[28]  G. Lippi,et al.  Cancer statistics: a comparison between World Health Organization (WHO) and Global Burden of Disease (GBD). , 2019, European journal of public health.

[29]  Run Shi,et al.  Immune Landscape of Invasive Ductal Carcinoma Tumor Microenvironment Identifies a Prognostic and Immunotherapeutically Relevant Gene Signature , 2019, Front. Oncol..

[30]  Yueming Sun,et al.  Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway , 2019, Journal of Experimental & Clinical Cancer Research.

[31]  Dan Xie,et al.  5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs , 2019, Nature Cell Biology.

[32]  Chuan He,et al.  RETRACTED ARTICLE: RNA m6A methylation regulates the epithelial mesenchymal transition of cancer cells and translation of Snail , 2019, Nature Communications.

[33]  Chunxing Yang,et al.  YTHDF1 Regulates Tumorigenicity and Cancer Stem Cell-Like Activity in Human Colorectal Carcinoma , 2019, Front. Oncol..

[34]  M. Bohnsack,et al.  Eukaryotic 5-methylcytosine (m5C) RNA Methyltransferases: Mechanisms, Cellular Functions, and Links to Disease , 2019, Genes.

[35]  Zhongjun Liu,et al.  Y‐box binding protein‐1 promotes tumorigenesis and progression via the epidermal growth factor receptor/AKT pathway in spinal chordoma , 2018, Cancer science.

[36]  Wenyuan Zhao,et al.  The long noncoding RNA LINC00312 induces lung adenocarcinoma migration and vasculogenic mimicry through directly binding YBX1 , 2018, Molecular Cancer.

[37]  Boxian Huang,et al.  Increased N6‐methyladenosine causes infertility is associated with FTO expression , 2018, Journal of cellular physiology.

[38]  Chi Zhang,et al.  Reversible RNA Modification N1-methyladenosine (m1A) in mRNA and tRNA , 2018, Genom. Proteom. Bioinform..

[39]  Lai Wei,et al.  RNA N6‐methyladenosine methyltransferase‐like 3 promotes liver cancer progression through YTHDF2‐dependent posttranscriptional silencing of SOCS2 , 2018, Hepatology.

[40]  Keeho Park,et al.  Type 1 diabetes mellitus and risk of cancer: a meta-analysis of observational studies , 2018, Japanese journal of clinical oncology.

[41]  Q. Wang,et al.  Association of AlkB homolog 3 expression with tumor recurrence and unfavorable prognosis in hepatocellular carcinoma , 2018, Journal of gastroenterology and hepatology.

[42]  K. Somasundaram,et al.  Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance , 2018, Oncogene.

[43]  B. Ponder,et al.  ERα Binding by Transcription Factors NFIB and YBX1 Enables FGFR2 Signaling to Modulate Estrogen Responsiveness in Breast Cancer. , 2018, Cancer research.

[44]  Zhike Lu,et al.  m6A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells , 2017, Cell reports.

[45]  G. Prendergast,et al.  A Milestone Review on How Macrophages Affect Tumor Growth. , 2016, Cancer research.

[46]  Chengqi Yi,et al.  Transcriptome-wide mapping reveals reversible and dynamic N(1)-methyladenosine methylome. , 2016, Nature chemical biology.

[47]  Ash A. Alizadeh,et al.  Robust enumeration of cell subsets from tissue expression profiles , 2015, Nature Methods.

[48]  Z. Trajanoski,et al.  Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. , 2013, Immunity.

[49]  Justin Guinney,et al.  GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.

[50]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[51]  T. Triche,et al.  Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition. , 2009, Cancer cell.

[52]  J. Pollard,et al.  Distinct role of macrophages in different tumor microenvironments. , 2006, Cancer research.

[53]  F. Hauck,et al.  Intrinsic and extrinsic causes of malignancies in patients with primary immunodeficiency disorders , 2018, The Journal of allergy and clinical immunology.

[54]  Ming O. Li,et al.  Ontogeny of Tumor-associated Macrophages and Its Implication in Cancer Regulation. , 2016, Trends in cancer.

[55]  Bonnie F. Sloane,et al.  Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties. , 2014, The international journal of biochemistry & cell biology.

[56]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..